The COVID-19 pandemic has highlighted the vital role of diagnostic testing in the monitoring and management of infectious diseases, and has further led to innovative efforts in academia and industry to improve testing technology and practices. There is abundant opportunity to apply lessons learned from the pandemic to other disease outbreaks, which each have their own unique diagnostic and treatment challenges to overcome. Sexually transmitted infections (STIs) represent a group of diseases for which comprehensive screening and surveillance would greatly benefit public health, but for which significant hurdles exist in terms of access to testing and, in some cases, detection sensitivity.
Read more on Labcompare.